Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China · Delayed Price · Currency is CNY 46.58
-6.42 (-12.11%)
Nov 13, 2026, 3:00 PM CST
SHA:688799 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,225 | 6,264 | 3,928 | 4,591 | 2,986 | 3,862 | |
Market Cap Growth | -2.90% | 59.46% | -14.43% | 53.75% | -22.69% | - |
Enterprise Value | 6,824 | 6,320 | 3,696 | 4,184 | 2,376 | 3,094 |
Last Close Price | 46.58 | 47.51 | 29.45 | 33.70 | 21.42 | 27.10 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 55.78 | 26.29 | 23.91 | 21.72 | 16.33 | 24.02 |
Forward PE | 33.51 | 31.23 | 12.74 | - | - | - |
PS Ratio | 4.49 | 4.16 | 2.78 | 3.20 | 2.31 | 3.37 |
PB Ratio | 2.90 | 3.07 | 2.15 | 2.60 | 1.80 | 2.61 |
P/TBV Ratio | 3.15 | 3.34 | 2.48 | 2.84 | 2.01 | 2.72 |
P/FCF Ratio | - | - | - | 42.24 | 125.46 | 170.68 |
P/OCF Ratio | 16.76 | 20.87 | 27.62 | 21.41 | 19.18 | 33.66 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.93 | 4.20 | 2.62 | 2.92 | 1.84 | 2.70 |
EV/EBITDA Ratio | 30.75 | 28.05 | 17.75 | 15.85 | 11.01 | 16.27 |
EV/EBIT Ratio | 46.84 | 40.98 | 26.60 | 20.62 | 14.23 | 19.85 |
EV/FCF Ratio | - | - | - | 38.50 | 99.86 | 136.75 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.40 | 0.24 | 0.07 | 0.01 | - | - |
Debt / EBITDA Ratio | 3.88 | 2.21 | 0.57 | 0.06 | - | - |
Debt / FCF Ratio | - | - | - | 0.16 | - | - |
Net Debt / Equity Ratio | 0.28 | 0.12 | -0.30 | -0.41 | -0.42 | -0.51 |
Net Debt / EBITDA Ratio | 2.75 | 1.04 | -2.59 | -2.75 | -3.23 | -3.96 |
Net Debt / FCF Ratio | -2.92 | -1.06 | 5.89 | -6.69 | -29.33 | -33.30 |
Asset Turnover | 0.43 | 0.55 | 0.61 | 0.69 | 0.68 | 0.84 |
Inventory Turnover | 1.48 | 1.48 | 1.41 | 1.46 | 1.32 | 1.31 |
Quick Ratio | 0.89 | 1.33 | 2.15 | 2.77 | 2.99 | 3.41 |
Current Ratio | 1.81 | 2.86 | 3.42 | 4.01 | 4.23 | 4.65 |
Return on Equity (ROE) | 5.50% | 11.80% | 7.73% | 11.27% | 11.05% | 15.01% |
Return on Assets (ROA) | 2.81% | 3.50% | 3.75% | 6.06% | 5.48% | 7.17% |
Return on Invested Capital (ROIC) | 4.51% | 8.21% | 10.26% | 17.03% | 17.61% | 21.25% |
Return on Capital Employed (ROCE) | 4.70% | 5.80% | 6.80% | 11.00% | 9.70% | 10.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.79% | 3.80% | 4.18% | 4.60% | 6.12% | 4.16% |
FCF Yield | -3.30% | -3.51% | -2.33% | 2.37% | 0.80% | 0.59% |
Dividend Yield | 0.38% | 0.38% | 2.01% | 1.84% | 2.83% | 1.70% |
Payout Ratio | 35.70% | 26.42% | 52.55% | 39.96% | 35.92% | - |
Buyback Yield / Dilution | -3.70% | -2.41% | 0.03% | -0.19% | -17.21% | -13.60% |
Total Shareholder Return | -3.32% | -2.03% | 2.03% | 1.65% | -14.38% | -11.90% |